Results 61 to 70 of about 1,416,559 (254)

Vascularised pancreas transplantation [PDF]

open access: yesBMJ, 1996
In vascularised pancreas transplantation the organ is transplanted as a whole (as opposed to islet cell transplantation, which is still experimental). The procedure re-establishes endogenous secretion of insulin that is responsive to normal feedback controls and is currently the only known treatment for diabetes that reliably achieves a euglycaemic ...
openaire   +2 more sources

Pancreas Transplantation: An Alarming Crisis in Confidence

open access: yesAmerican Journal of Transplantation, 2016
In the past decade, the annual number of pancreas transplantations performed in the United States has steadily declined. From 2004 to 2011, the overall number of simultaneous pancreas–kidney (SPK) transplantations in the United States declined by 10 ...
R. Stratta   +4 more
semanticscholar   +1 more source

A comparative study on outcomes of ABO-incompatible kidney transplants between robot-assisted vs. open surgery-propensity score-matched analysis: a retrospective cohort study

open access: yesBMC Nephrology
Background Robot-assisted kidney transplantation (RAKT) is increasingly being adopted worldwide. Despite this growing interest, there remains a notable gap in the literature, especially concerning its effectiveness in immunologically high-risk patients ...
Jin-Myung Kim   +6 more
doaj   +1 more source

Innovative strategies in kidney paired donation: single-center experience achieving the highest annual transplant volume globally

open access: yesFrontiers in Immunology
BackgroundKidney Paired Donation (KPD) programs expand transplant opportunities for immunologically incompatible donor-recipient pairs. This study describes the operational framework and clinical outcomes of a high-volume, single-center KPD program ...
Khalid A. AlMeshari   +6 more
doaj   +1 more source

Demographic profile in liver transplant candidates on waiting list

open access: yesBrazilian Journal of Transplantation, 2010
Liver transplantation is a life-saving therapy for patients with end-stage liver diseases. The post-transplant outcome depends on a wide knowledge of the patient's status and factors that may influence results and complications, as well as an ...
Camila César Winckler   +8 more
doaj   +1 more source

The Coming Age of Antisense Oligos for the Treatment of Hepatic Ischemia/Reperfusion (IRI) and Other Liver Disorders: Role of Oxidative Stress and Potential Antioxidant Effect

open access: yesAntioxidants
Imbalances in the redox state of the liver arise during metabolic processes, inflammatory injuries, and proliferative liver disorders. Acute exposure to intracellular reactive oxygen species (ROS) results from high levels of oxidative stress (OxS) that ...
Siyuan Yao   +5 more
doaj   +1 more source

In Vivo Imaging of Transplanted Islets with ^(64)Cu-DO3A-VS-Cys^(40)-Exendin-4 by Targeting GLP-1 Receptor [PDF]

open access: yes, 2011
Glucagon-like peptide 1 receptor (GLP-1R) is highly expressed in pancreatic islets, especially on β-cells. Therefore, a properly labeled ligand that binds to GLP-1R could be used for in vivo pancreatic islet imaging.
Bading, James R.   +11 more
core   +2 more sources

Risk indices predicting graft use, graft and patient survival in solid pancreas transplantation: a systematic review

open access: yesBMC Gastroenterology, 2021
Background Risk indices such as the pancreas donor risk index (PDRI) and pre-procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas transplantation however no review has compared all derived and validated indices in ...
Jonathan E. H. Ling   +3 more
doaj   +1 more source

Treatment of a mixed acinar-endocrine carcinoma with uptake on 68Gallium-DOTATOC positron emission tomography-computed tomography : a case report [PDF]

open access: yes, 2017
The case of a 35-year old female patient with a diagnosis of metastatic mixed acinar-endocrine carcinoma (MAEC) is investigated in the present study.
De Both, Anneleen   +5 more
core   +2 more sources

Weaning of immunosuppression in liver transplant recipients [PDF]

open access: yes, 1997
Immunosuppression has been sporadically discontinued by noncompliant liver allograft recipients for whom an additional 4 1/2 years of follow-up is provided.
Anand   +26 more
core   +1 more source

Home - About - Disclaimer - Privacy